Cargando…
A new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of SSTR2 and Bcl2
BACKGROUND: No universal classification method for intrahepatic cholangiocarcinoma (IHCC) has been reported based on the embryological origin of biliary epithelial cells. The aim of this study was to classify IHCC according to protein expression levels of somatostatin receptor 2 (SSTR2) and b-cell l...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106133/ https://www.ncbi.nlm.nih.gov/pubmed/33962620 http://dx.doi.org/10.1186/s12957-021-02216-3 |
_version_ | 1783689723124908032 |
---|---|
author | Yamashita, Shoko Morine, Yuji Imura, Satoru Ikemoto, Tetsuya Saito, Yu Takasu, Chie Yamada, Shinichiro Tokuda, Kazunori Okikawa, Shohei Miyazaki, Katsuki Oya, Takeshi Tsuneyama, Koichi Shimada, Mitsuo |
author_facet | Yamashita, Shoko Morine, Yuji Imura, Satoru Ikemoto, Tetsuya Saito, Yu Takasu, Chie Yamada, Shinichiro Tokuda, Kazunori Okikawa, Shohei Miyazaki, Katsuki Oya, Takeshi Tsuneyama, Koichi Shimada, Mitsuo |
author_sort | Yamashita, Shoko |
collection | PubMed |
description | BACKGROUND: No universal classification method for intrahepatic cholangiocarcinoma (IHCC) has been reported based on the embryological origin of biliary epithelial cells. The aim of this study was to classify IHCC according to protein expression levels of somatostatin receptor 2 (SSTR2) and b-cell leukemia/lymphoma 2 (Bcl2) and to elucidate the clinicopathological features of each group. METHODS: Fifty-two IHCC patients who underwent hepatic resection were enrolled in this study. Protein expression levels of SSTR2 and Bcl2 were examined using immunohistochemistry. Clinicopathological factors were compared between the three groups and prognostic factors were investigated. RESULTS: The patients were divided into three groups: SSTR2 positive and Bcl2 negative (p-Group H, n = 21), SSTR2 negative and Bcl2 positive (p-Group P, n = 14), and the indeterminate group (p-Group U, n = 17) for cases where SSTR2 and Bcl2 were both positive or both negative. All p-Group P cases displayed curability A or B. The 5-year survival rates of p-Group H and U patients were worse than those in p-Group P. p-Group H had higher T-factor, clinical stage, and incidence of periductal infiltration than p-Group P. CONCLUSIONS: This method could be used to classify IHCC into peripheral and perihilar type by embryological expression patterns of SSTR2 and Bcl2. |
format | Online Article Text |
id | pubmed-8106133 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-81061332021-05-10 A new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of SSTR2 and Bcl2 Yamashita, Shoko Morine, Yuji Imura, Satoru Ikemoto, Tetsuya Saito, Yu Takasu, Chie Yamada, Shinichiro Tokuda, Kazunori Okikawa, Shohei Miyazaki, Katsuki Oya, Takeshi Tsuneyama, Koichi Shimada, Mitsuo World J Surg Oncol Research BACKGROUND: No universal classification method for intrahepatic cholangiocarcinoma (IHCC) has been reported based on the embryological origin of biliary epithelial cells. The aim of this study was to classify IHCC according to protein expression levels of somatostatin receptor 2 (SSTR2) and b-cell leukemia/lymphoma 2 (Bcl2) and to elucidate the clinicopathological features of each group. METHODS: Fifty-two IHCC patients who underwent hepatic resection were enrolled in this study. Protein expression levels of SSTR2 and Bcl2 were examined using immunohistochemistry. Clinicopathological factors were compared between the three groups and prognostic factors were investigated. RESULTS: The patients were divided into three groups: SSTR2 positive and Bcl2 negative (p-Group H, n = 21), SSTR2 negative and Bcl2 positive (p-Group P, n = 14), and the indeterminate group (p-Group U, n = 17) for cases where SSTR2 and Bcl2 were both positive or both negative. All p-Group P cases displayed curability A or B. The 5-year survival rates of p-Group H and U patients were worse than those in p-Group P. p-Group H had higher T-factor, clinical stage, and incidence of periductal infiltration than p-Group P. CONCLUSIONS: This method could be used to classify IHCC into peripheral and perihilar type by embryological expression patterns of SSTR2 and Bcl2. BioMed Central 2021-05-07 /pmc/articles/PMC8106133/ /pubmed/33962620 http://dx.doi.org/10.1186/s12957-021-02216-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Yamashita, Shoko Morine, Yuji Imura, Satoru Ikemoto, Tetsuya Saito, Yu Takasu, Chie Yamada, Shinichiro Tokuda, Kazunori Okikawa, Shohei Miyazaki, Katsuki Oya, Takeshi Tsuneyama, Koichi Shimada, Mitsuo A new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of SSTR2 and Bcl2 |
title | A new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of SSTR2 and Bcl2 |
title_full | A new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of SSTR2 and Bcl2 |
title_fullStr | A new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of SSTR2 and Bcl2 |
title_full_unstemmed | A new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of SSTR2 and Bcl2 |
title_short | A new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of SSTR2 and Bcl2 |
title_sort | new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of sstr2 and bcl2 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106133/ https://www.ncbi.nlm.nih.gov/pubmed/33962620 http://dx.doi.org/10.1186/s12957-021-02216-3 |
work_keys_str_mv | AT yamashitashoko anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT morineyuji anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT imurasatoru anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT ikemototetsuya anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT saitoyu anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT takasuchie anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT yamadashinichiro anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT tokudakazunori anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT okikawashohei anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT miyazakikatsuki anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT oyatakeshi anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT tsuneyamakoichi anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT shimadamitsuo anewpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT yamashitashoko newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT morineyuji newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT imurasatoru newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT ikemototetsuya newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT saitoyu newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT takasuchie newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT yamadashinichiro newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT tokudakazunori newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT okikawashohei newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT miyazakikatsuki newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT oyatakeshi newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT tsuneyamakoichi newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 AT shimadamitsuo newpathologicalclassificationofintrahepaticcholangiocarcinomaaccordingtoproteinexpressionofsstr2andbcl2 |